The University of Leicester is a public research university based in Leicester, England. The main campus is south of the city centre, adjacent to Victoria Park. The university's predecessor, University College, Leicester, gained university status in 1957.

During the past decade, University of Leicester conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Leicester" #1 sponsor was "University of Leicester" with 16 trials, followed by "Verastem, Inc." with 2 trials sponsored, "Amphera BV" with 1 trials sponsored, "Brahms AG" with 1 trials sponsored and "Gilead Sciences" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Leicester" #1 collaborator was "University Hospitals, Leicester" with 4 trials as a collaborator, "A.O. Ospedale Papa Giovanni XXIII" with 1 trials as a collaborator, "Accelopment AG" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator and "CNET Svenska AB" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "University of Leicester" are "Diabetes Mellitus, Type 2" (3 trials), "Cardiovascular Diseases" (2 trials), "Chronic Kidney Diseases" (2 trials), "Coronary Artery Disease" (2 trials) and "Heart Failure" (2 trials). Many other conditions were trialed in "University of Leicester" in a lesser frequency.

Most popular intervention types in "University of Leicester" are "Other" (7 trials), "Diagnostic Test" (6 trials), "Drug" (6 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Accelerometer watch" (1 trials), "Ambulatory blood pressure monitoring" (1 trials), "Blood tests" (1 trials) and "Cardiopulmonary exercise testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Leicester" are 24 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Leicester". 1 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University of Leicester, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Leicester, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".

University of Leicester has several departments that took part in Clinical trials: "Department of Cardiovascular Sciences" - 4 trials